RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Results from CURRENT-OASIS 7
JF MD Conference Express
YR 2009
FD SAGE Publications
VO 9
IS 4
SP 15
OP 16
DO 10.1177/155989770904009
UL http://mdc.sagepub.com/content/9/4/15.abstract
AB The Clopidogrel optimal loading dose Usage to Reduce Recurrent Events-Organization to Assess Strategies in Ischemic Syndromes [CURRENT-OASIS 7] trial was a 2×2 factorial, open-label, randomized trial to determine optimal clopidogrel and aspirin dosing in subjects with acute coronary syndrome within 24 hours of ischemic symptoms. The primary outcome was a composite of cardiovascular death, myocardial infarction, or stroke to Day 30.